Cyclodextrin/Fe3O4 magnetic nano composite and medicinal inclusion compound thereof
A technology of magnetic nanoparticles and magnetic nanoparticles, which is applied in drug combinations, antipyretics, pharmaceutical formulations, etc., can solve the problems of frequent medication to maintain therapeutic concentration, strong gastrointestinal stimulation, low dissolution rate and bioavailability, etc. , to achieve significant solubilization effect, improve solubility and increase drug stability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0020] Example 1: Fe 3 o 4 Preparation of Magnetic Nanoparticles
[0021] (1) Weigh FeCl with a molar ratio of 1:1 2 .4H 2 O and FeCl 3 .6H 2O (total iron concentration 0.3mol / L) is placed in a 250ml round bottom flask, add an appropriate amount of twice distilled water 194ml, fully stir and dissolve at a speed of 600r / min at a temperature of 30°C, and simultaneously add concentrated ammonia water (25-28%) When the pH is 9 to complete the precipitation, heat up to 80°C and mature for 30 minutes. The reactant is naturally cooled to room temperature, washed repeatedly with double distilled water and ethanol, separated by a permanent magnet, and vacuum-dried at 70°C for 24 hours to obtain Fe 3 o 4 Magnetic nanoparticles (MNP) (see figure 1 ).
[0022] Characterized by X-ray diffraction technique, from figure 2 It can be seen that the peaks at 2θ at 30.2, 35.6, 43.2, 53.7, 57.2 and 62.9 correspond to the face-centered cubic Fe 3 o 4 The (220), (311), (400), (422), (511...
Embodiment 2
[0034] Embodiment 2: sulfobutyl ether-β-cyclodextrin / Fe 3 o 4 Inclusion Compound of Magnetic Nanocomposite and Ibuprofen
[0035] sulfobutyl ether-β-cyclodextrin / Fe 3 o 4 Add 20 mg of the magnetic nanocomposite to the ethanol solution of ibuprofen (containing 16.83 mg ibuprofen), react with ultrasound for 4 hours, wash the product with twice distilled water, separate it with a permanent magnet, and dry it at 50°C for 10 hours to obtain sulfobutyl ether- β-Cyclodextrin / Fe 3 o 4 The inclusion compound of the magnetic nanocomposite and ibuprofen has a measured inclusion rate of 60.91%, and the actual drug content of the inclusion compound is 10.25 mg / g.
Embodiment 3
[0036] Embodiment 3: Sulfonyl ether-β-cyclodextrin / Fe 3 o 4 Inclusion Compound of Magnetic Nanocomposite and Ibuprofen
[0037] sulfobutyl ether-β-cyclodextrin / Fe 3 o 4 Add 20 mg of magnetic nanocomposite to ethanol solution of ibuprofen (containing 9.85 mg ibuprofen), react with ultrasound for 4 hours, wash the product with twice distilled water, separate it with a permanent magnet, and dry it at 50°C for 10 hours to obtain sulfobutyl ether- β-Cyclodextrin / Fe 3 o 4 The inclusion compound of the magnetic nanocomposite and ibuprofen has a measured inclusion rate of 57.46%, and the actual drug content of the inclusion compound is 5.66 mg / g.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com